Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Personnel
Hyam I. Levitsky, MD, joins Antigenics' board of directors
October 11th, 2006
Antigenics, Inc., (AGEN) announced the appointment of Hyam I. Levitsky, MD, to its board of directors. Currently a professor of oncology, medicine, and urology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, the scientific director of Johns Hopkins' George Santos Bone Marrow Transplant Program, and a member of the Cancer Vaccine Consortium's executive council, Levitsky's appointment brings more than 15 years of clinical and research experience to Antigenics' board of directors. "Hy's research has formed the basis for the development of several novel immunotherapeutic agents for a variety of different cancers," said Garo H. Armen,...
Source: Vaccine Weekly (2006-10-11)
|
